Neoplasm Metastases Clinical Trial
Official title:
Neurocognition After Gamma Knife Radiosurgery for Multiple Brian Metastases
Cancer which spreads to the brain (brain metastases) is a common and significant problem. Historically, whole-brain radiotherapy has been used to treat these patients but has a negative effect on cognition. Radiosurgery is an alternative treatment with potential for fewer cognitive side effects. The impact of radiosurgery alone on the cognitive function of patients with multiple brain metastases is not well studied. We propose a pilot study at the Winnipeg Centre for Gamma Knife Surgery to examine this issue.
Patients with >=4 brain metastases will undergo Gamma Knife radiosurgery to a dose of 15-20 Gy, depending on the maximum tumour diameter and number of metastases. A number of neurocognitive, quality of life, and toxicity assessments will be performed at baseline and at 6 weeks post-radiosurgery, then at months 4, 6, 12, 18, and every 6 months thereafter. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03911388 -
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
|
Phase 1 | |
| Completed |
NCT02953756 -
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
|
||
| Terminated |
NCT02565433 -
Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)
|
N/A | |
| Completed |
NCT00184353 -
Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.
|
N/A | |
| Recruiting |
NCT02789371 -
Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions
|
N/A | |
| Completed |
NCT01122199 -
Study of RAD001 + AMG479 for Patients With Advanced Solid Tumors
|
Phase 1 | |
| Terminated |
NCT01336985 -
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
|
Phase 1 | |
| Recruiting |
NCT05419518 -
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
|
Phase 2 | |
| Completed |
NCT02808416 -
Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
|
Phase 1 | |
| Completed |
NCT00668382 -
Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection
|
Phase 1 | |
| Completed |
NCT00152906 -
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
|
Phase 1/Phase 2 | |
| Completed |
NCT01267084 -
A Study to Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02327065 -
Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion
|
N/A | |
| Completed |
NCT02382653 -
Oral Piroxicam Versus Buccal Fentanyl in Breakthrough Pain
|
N/A | |
| Completed |
NCT01273493 -
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
|
Phase 1 | |
| Completed |
NCT01273480 -
A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies
|
Phase 1 | |
| Completed |
NCT00556049 -
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
|
Phase 2 | |
| Recruiting |
NCT02246634 -
Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)
|
N/A |